07971459383

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

MabTas 100 Rituximab Concentrate Injection

Name: MabTas 100 Rituximab Concentrate Injection
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 2200 INR
Availability: InStock

Price 2200 INR/ Unit

Get a Price/Quote

MOQ : 1 Unit

MabTas 100 Rituximab Concentrate Injection Specification

Life Span
3 Years

Salt Composition
Rituximab

Packaging Type
Glass vial

Pacakaging (Quantity Per Box)
1 vial

Dosage Form
Injection

Brand Name
MabTas

Indication
Non-Hodgkin lymphoma, rheumatoid arthritis, blood cancer

Origin of Medicine
India

Drug Type
Biological/Monoclonal Antibody

Ingredients
Rituximab (100mg)

Physical Form
Liquid Concentrate

Function
Anti-cancer monoclonal antibody

Recommended For
Non-Hodgkin lymphoma, rheumatoid arthritis, blood cancer

Dosage
As prescribed by physician

Dosage Guidelines
Intravenous infusion under supervision

Suitable For
Adults

Quantity
100mg per vial

Storage Instructions
Store at 2C to 8C

Glass Bottle Packaging
Yes

Prescription Required
Yes

Colourless Solution
Yes

Concentration Strength
100mg/10ml

PCD Pharma Deal
Available

Single Use Vial
Yes

Marketed By
Intas

Route of Administration
IV infusion

MabTas 100 Rituximab Concentrate Injection Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About MabTas 100 Rituximab Concentrate Injection

Experience the remarkable power of MabTas 100 Rituximab Concentrate Injection-now on a limited time sale! Grab yours and access formidable, elite medical support for conditions like Non-Hodgkin lymphoma, blood cancer, and rheumatoid arthritis. Marketed by Intas, this colourless liquid concentrate comes in a 100mg/10ml single-use glass vial, designed exclusively for adult IV infusion. With its trusted biological monoclonal antibody formulation, MabTas delivers dependable outcomes. Secure your vial today-prescription required- and take advantage of this exclusive PCD Pharma Deal. Premium quality, maximum efficacy!

MabTas 100: Elite Anti-Cancer Solution for Adults

MabTas 100 Rituximab Concentrate Injection is expertly formulated as a premium monoclonal antibody for treating Non-Hodgkin lymphoma, rheumatoid arthritis, and certain blood cancers. It comes in a single-use glass vial, delivering a precise dose of 100mg/10ml via IV infusion. With its colourless, liquid form and stringent storage requirements, MabTas guarantees safety and effectiveness in hospital and clinical settings, offering adults an advanced solution against challenging immune and cancer-related conditions.

Sample Policy, Premium Valuation, and Reliable Supply Terms

MabTas 100 Rituximab Injection is available with a clear sample policy for eligible distribution partners, ensuring product familiarity before bulk procurement. Payment terms are flexible to align with customer needs while upholding premium standards. The injection holds necessary medical certifications, guaranteeing authenticity and safety. Backed by reliable supply chains and valued for its formidable therapeutic profile, the product is trusted by exporters, suppliers, and traders across India. Experience assured quality and consistency every time.

FAQ's of MabTas 100 Rituximab Concentrate Injection:

Q: How is MabTas 100 Rituximab Concentrate Injection administered?

A: MabTas 100 Rituximab is administered through intravenous (IV) infusion under the careful supervision of a healthcare professional, following the dosage prescribed by your physician.

Q: What are the primary uses of MabTas 100 Injection?

A: MabTas 100 is recommended for adults in the treatment of Non-Hodgkin lymphoma, blood cancer, and rheumatoid arthritis, providing targeted anti-cancer and immunomodulatory effects.

Q: When should MabTas 100 Rituximab be used?

A: MabTas 100 should be used only when prescribed by a qualified healthcare provider, typically after diagnosis of conditions such as Non-Hodgkin lymphoma, certain blood cancers, or rheumatoid arthritis.

Q: Where should MabTas 100 Injection be stored for maximum efficacy?

A: MabTas 100 must be stored at a temperature between 2C and 8C in its original glass vial packaging until use, ensuring its stability and effectiveness are preserved.

Q: What makes MabTas 100 Injection a premium choice for therapy?

A: MabTas 100 is a biological monoclonal antibody produced by Intas, known for its elite therapeutic action, stringent quality standards, and proven results in adult patients with serious oncological or autoimmune conditions.

Q: How can one obtain MabTas 100 for pharmaceutical distribution or supply?

A: To acquire MabTas 100 for distribution or export, contact an authorized Intas supplier or trader in India. PCD Pharma deals are available, supporting bulk and specialty supply arrangements.